Nickol A D, Bonventre P F
Infect Immun. 1985 Oct;50(1):169-74. doi: 10.1128/iai.50.1.169-174.1985.
This paper continues a comparative study (A. D. Nickol and P. F. Bonventre, Infect. Immun. 50:160-168, 1985) describing immune responses exhibited by congenic, Lshs mouse strains C57B1/10 (cure) and B10.D2 (noncure) during the course of disseminated leishmaniasis. We report that sublethal whole-body irradiation of B10.D2 mice before challenge with Leishmania donovani converted the noncuring mice to a curing phenotype. Splenic lymphocytes from L. donovani-infected B10.D2 mice failed to proliferate in response to parasite antigen stimulation in vitro. Splenic lymphocytes from irradiated, cured B10.D2 mice regained the capacity to respond to the parasite antigen stimulus. Transfer of T cells but not B cells from L. donovani-infected B10.D2 mice prevented the acquisition of immunity and recovery from infection in X-irradiated mice. In addition, a splenic T-cell population from L. donovani-infected B10.D2 mice suppressed the proliferation in vitro of parasite antigen-stimulated lymphocytes of irradiation-cured B10.D2 mice. Suppressor T cells were not demonstrable in the spleens of spontaneously cured C57B1/10 mice. Splenic lymphocytes from infected B10.D2 mice were deficient in the production of macrophage-activating factor (MAF) upon stimulation by L. donovani antigens in vitro. Deficient MAF production was specific for parasite antigen stimulation, because MAF production subsequent to concanavalin A stimulation of splenic lymphocytes from infected B10.D2 mice was not suppressed. The data suggest that a genetically based immunological defect in B10.D2 mice prevents the acquisition of effective cell-mediated immunity and subsequent elimination of L. donovani from tissue macrophages. The immunological deficit, not apparent in the curing C57B1/10, appears to be caused by the development of parasite antigen-specific suppressor T cells during the course of the disseminated leishmaniasis.
本文延续了一项比较研究(A.D. 尼科尔和P.F. 邦文特雷,《感染与免疫》50:160 - 168,1985年),该研究描述了同基因Lshs小鼠品系C57B1/10(治愈型)和B10.D2(非治愈型)在播散性利什曼病病程中表现出的免疫反应。我们报告,在用杜氏利什曼原虫攻击之前对B10.D2小鼠进行亚致死剂量的全身照射,可使非治愈小鼠转变为治愈表型。来自感染杜氏利什曼原虫的B10.D2小鼠的脾淋巴细胞在体外对寄生虫抗原刺激无增殖反应。来自经照射且治愈的B10.D2小鼠的脾淋巴细胞恢复了对寄生虫抗原刺激的反应能力。将感染杜氏利什曼原虫的B10.D2小鼠的T细胞而非B细胞转移到经X射线照射的小鼠中,可阻止其获得免疫力并从感染中恢复。此外,来自感染杜氏利什曼原虫的B10.D2小鼠的脾T细胞群体可抑制经照射治愈的B10.D2小鼠的寄生虫抗原刺激的淋巴细胞在体外的增殖。在自发治愈的C57B1/10小鼠的脾脏中未检测到抑制性T细胞。来自感染的B10.D2小鼠的脾淋巴细胞在体外受到杜氏利什曼原虫抗原刺激后,巨噬细胞激活因子(MAF)的产生不足。MAF产生不足是寄生虫抗原刺激所特有的,因为用刀豆球蛋白A刺激感染的B10.D2小鼠的脾淋巴细胞后,MAF的产生并未受到抑制。数据表明,B10.D2小鼠中基于遗传的免疫缺陷阻止了有效的细胞介导免疫的获得以及随后从组织巨噬细胞中清除杜氏利什曼原虫。在治愈型C57B1/10小鼠中不明显的免疫缺陷,似乎是由播散性利什曼病病程中寄生虫抗原特异性抑制性T细胞的发育引起的。